NasdaqGS - Nasdaq Real Time Price USD
Adaptive Biotechnologies Corporation (ADPT)
9.37
-0.14
(-1.47%)
As of 2:52:14 PM EDT. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
---|---|---|---|
BENZENO SHARON Officer | Sale | Mar 5, 2025 | 392,723 |
BOBULSKY SUSAN Officer | Sale | Mar 5, 2025 | 347,238 |
GRIFFIN MICHELLE RENEE Director | Sale | Mar 13, 2025 | 15,394 |
HERSHBERG ROBERT M Director | Sale | Mar 12, 2025 | 69,690 |
LO FRANCIS Officer | Sale | Mar 5, 2025 | 335,346 |
NEUPERT PETER M Director | Sale | Mar 10, 2025 | 224,690 |
PISKEL KYLE Chief Financial Officer | Conversion of Exercise of derivative security | Mar 14, 2025 | 271,510 |
ROBINS CHAD M Chief Executive Officer | Sale | Mar 6, 2025 | 2,959,250 |
ROBINS HARLAN S. Officer | Sale | May 1, 2025 | 1,279,520 |
RUBINSTEIN JULIAN President | Sale | Mar 5, 2025 | 588,249 |
Related Tickers
BEAM Beam Therapeutics Inc.
17.96
-1.54%
CRMD CorMedix Inc.
11.71
-1.26%
DNA Ginkgo Bioworks Holdings, Inc.
8.18
-1.62%
ARCT Arcturus Therapeutics Holdings Inc.
12.18
+5.08%
HALO Halozyme Therapeutics, Inc.
49.85
-25.14%
EDIT Editas Medicine, Inc.
1.4918
-3.13%
SPRC SciSparc Ltd.
0.3338
-6.47%
SNDX Syndax Pharmaceuticals, Inc.
10.30
-6.28%
KRYS Krystal Biotech, Inc.
135.52
-2.80%
BBIO BridgeBio Pharma, Inc.
33.61
-5.80%